Literature DB >> 20721832

Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.

Philip M Grant1, Andrew R Zolopa.   

Abstract

Potent antiretroviral therapy (ART) has transformed HIV infection into a chronic manageable disease, but drug resistance remains a common problem that limits the effectiveness and clinical benefits of treatment. With increasing experience with ART, the understanding of viral dynamics of HIV improved, and researchers learned how challenging HIV can be to control. With new-class and new-generation drugs, it is hoped that the lessons learned will be useful for limiting drug resistance and optimizing the use of ART for long-term management of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20721832

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  3 in total

1.  Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.

Authors:  Wei Zhao; Massimo Cella; Oscar Della Pasqua; David Burger; Evelyne Jacqz-Aigrain
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

2.  Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.

Authors:  Priyamvada Acharya; Cajetan Dogo-Isonagie; Judith M LaLonde; Son N Lam; George J Leslie; Mark K Louder; Leah L Frye; Asim K Debnath; Jeremy R Greenwood; Timothy S Luongo; Loïc Martin; K Shawn Watts; James A Hoxie; John R Mascola; Carole A Bewley; Peter D Kwong
Journal:  ACS Chem Biol       Date:  2011-08-05       Impact factor: 5.100

Review 3.  Structural insights on the role of antibodies in HIV-1 vaccine and therapy.

Authors:  Anthony P West; Louise Scharf; Johannes F Scheid; Florian Klein; Pamela J Bjorkman; Michel C Nussenzweig
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.